组蛋白去乙酰化酶-6 调节 4°C 血小板对血管内皮通透性的影响。

Histone deacetylase-6 modulates the effects of 4°C platelets on vascular endothelial permeability.

机构信息

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA.

Department of Pediatrics, University of California, San Francisco, San Francisco, CA.

出版信息

Blood Adv. 2023 Apr 11;7(7):1241-1257. doi: 10.1182/bloodadvances.2022007409.

Abstract

Platelets (PLTs) stored at 4°C exhibit equivalent or superior hemostatic function compared with 22°C PLTs, but have shorter circulation times and a decreased ability to modulate vascular permeability. These differences may be due to morphological changes and storage-induced activation. Using a proteomics-based approach, we found that 4°C-stored PLTs express decreased α-tubulin, a key PLT structural protein. PLT activation is characterized by α-tubulin deacetylation, which is regulated by histone deacetylase-6 (HDAC-6). We hypothesized that inhibition of HDAC-6 in stored PLTs will improve their ability to regulate vascular permeability through reduced activation and α-tubulin deacetylation. In an in vivo model of vascular permeability, treatment of 4°C PLTs with the HDAC-6 inhibitor tubacin enhanced the vasculoprotective properties of untreated 4°C PLTs. 4°C PLT circulation, however, was unchanged by tubacin treatment, suggesting that circulation time may not be a critical factor in determining the vasculoprotective effects of PLTs. Assessing the factor content of stored PLTs revealed that angiopoietin-1 (Ang-1) increased in 4°C PLTs over time, which was further enhanced by tubacin treatment. In addition, angiopoietin-2, an inducer of vascular leak and antagonist of Ang-1, inhibited PLT barrier protection, suggesting involvement of the Tie-2 pathway. This study demonstrates that HDAC-6 inhibition with tubacin attenuates the diminished vasculo-protective properties of 4°C PLTs, and these properties may be independent of PLT circulation time.

摘要

在 4°C 下储存的血小板 (PLT) 表现出与 22°C PLT 相当或更好的止血功能,但循环时间更短,调节血管通透性的能力下降。这些差异可能是由于形态变化和储存诱导的激活。使用基于蛋白质组学的方法,我们发现 4°C 储存的 PLT 表达减少的α-微管蛋白,这是一种关键的 PLT 结构蛋白。PLT 的激活特征是α-微管蛋白去乙酰化,这受组蛋白去乙酰化酶-6 (HDAC-6) 调控。我们假设在储存的 PLT 中抑制 HDAC-6 将通过减少激活和α-微管蛋白去乙酰化来改善其调节血管通透性的能力。在血管通透性的体内模型中,用 HDAC-6 抑制剂 tubacin 处理 4°C PLT 增强了未经处理的 4°C PLT 的血管保护特性。然而,4°C PLT 的循环不受 tubacin 处理的影响,这表明循环时间可能不是决定 PLT 血管保护作用的关键因素。评估储存的 PLT 的因子含量显示,Angiopoietin-1 (Ang-1) 随时间在 4°C PLT 中增加,并用 tubacin 处理进一步增强。此外,血管渗漏诱导因子和 Ang-1 的拮抗剂血管生成素-2 抑制 PLT 屏障保护,提示 Tie-2 途径的参与。这项研究表明,用 tubacin 抑制 HDAC-6 可减轻 4°C PLT 减弱的血管保护特性,并且这些特性可能与 PLT 循环时间无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a9e/10090218/efc4d9ffc52d/BLOODA_ADV-2022-007409-fx1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索